ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - amoxicillin trihydrate 250 mg - capsules - amoxicillin - infections caused by amoxicillin - susceptible organisms. prevention of bacteremia in patients at risk of developing bacterial endocarditis.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - cloxacillin as sodium - אבקה להכנת תמיסה לזריקה - cloxacillin as sodium 2 g/vial - cloxacillin - cloxacillin - for the treatment of infections caused by penicillinase-producing staphylococci. because of the high incidence of staphylococcal isolates resistant to penicillin g both within and outside the hospiral environment . orbenil is recommended as initial therapy in patients with suspected staphylococcal infections. orebenil is also effective in the treatment of other commonly encountered gram-positive coccal infections.typical indications include: - respiratory tract infections such as pneumonia and sinusitis - infected wounds and burns - osteomyelitis and septic arthritis - other infections due to staphylococci (including penicillin-resistant strains) such as septicemia endocarditis enterocolitis and urinary tract infections.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - cefonicide as sodium - אבקה להכנת תמיסה לזריקה - cefonicide as sodium 1000 mg/vial - cefonicide - cefonicide - treatment of serious bacterial infections caused by microorganisms susceptible to cefonicid. studies on specimens obtained prior to therapy should be used to determine the susceptibility or the causative organisms to cefonicid.therapy with cefonicid may be initiated pending results of the studies however.treatment should be adjusted according to study findings. cefonicid-teva is indicated in the treatment of the infections of the lower respiratory tract urinary tract skin and skin structure bone and joints. in the treatment of the above-mentioned infections the product is particularly used in weak and/or immuno-depressed patients. surgical prophylaxis: the administration of a single 1 g. dose of cefonicid-teva before surgery may reduce the incidence of post-operative infections caused by susceptible microorganisms in patients undergoing surgical procedures classified as contaminated or potentially contaminated or in patients in whom infection at the operative site would present a serious risk providing protec

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - meropenem as trihydrate 1000 mg - powder for solution for inj/inf - meropenem - meropenem teva is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meropenem teva has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - fluconazole 100 mg - capsules - fluconazole - cryptococcosis. - systemic candidiasis. - mucosal candidiasis. - vaginal candidiasis. - dermatomycosis.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - fluconazole 2 mg / 1 ml - solution for infusion - fluconazole - cryptococcosis, systemic candidiasis, mucosal candidiasis.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - methotrexate 1000 mg / 10 ml - solution for injection - methotrexate - antineoplastic chemotherapy.psoriasis. rheumatoid arthritis.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - fludarabine phosphate 50 mg / 2 ml - concentrate for solution for injection / infusion - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine teva is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - gemcitabine as hydrochloride 200 mg/vial - powder for solution for injection - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

ישראל - עברית - Ministry of Health

salomon,levin & elstein ltd - gemcitabine as hydrochloride 1000 mg/vial - powder for solution for injection - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.